tiprankstipranks
Trending News
More News >
Summit Therapeutics (SMMT)
NASDAQ:SMMT
US Market

Summit Therapeutics (SMMT) Ratios

Compare
1,532 Followers

Summit Therapeutics Ratios

SMMT's free cash flow for Q1 2025 was £0.00. For the 2025 fiscal year, SMMT's free cash flow was decreased by £ and operating cash flow was £0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
6.27 9.30 16.93 3.80 3.34
Quick Ratio
6.27 9.30 9.16 3.52 3.93
Cash Ratio
5.05 3.50 8.99 2.80 3.34
Solvency Ratio
-1.57 -4.18 -0.13 -2.78 -2.20
Operating Cash Flow Ratio
-1.57 -3.76 -1.07 -2.83 -2.42
Short-Term Operating Cash Flow Coverage
-24.60 0.00 -2.10 -255.37 0.00
Net Current Asset Value
£ 47.77M£ 64.45M£ 119.20M£ 67.22M£ 43.37M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 0.52 0.78 0.02 <0.01
Debt-to-Equity Ratio
0.01 1.37 4.10 0.03 <0.01
Debt-to-Capital Ratio
0.01 0.58 0.80 0.03 <0.01
Long-Term Debt-to-Capital Ratio
0.00 0.56 0.80 0.00 0.00
Financial Leverage Ratio
1.23 2.61 5.24 1.36 1.29
Debt Service Coverage Ratio
-18.45 0.12 -2.00 -106.65 -144.79
Interest Coverage Ratio
-1.31K -5.45 -16.38 -306.71 -208.60
Debt to Market Cap
<0.01 0.06 0.63 <0.01 0.00
Interest Debt Per Share
<0.01 0.20 2.71 0.03 0.01
Net Debt to EBITDA
2.93 34.64 -3.23 1.10 1.78
Profitability Margins
Gross Profit Margin
75.41%0.00%-256.95%100.00%100.00%
EBIT Margin
-3579.72%0.00%-10561.06%-4884.47%-6122.67%
EBITDA Margin
-2657.39%0.00%-7472.75%-3467.99%-4317.95%
Operating Profit Margin
-6766.39%0.00%-10235.63%-4764.29%-6185.23%
Pretax Profit Margin
-4494.86%0.00%-11185.94%-4897.84%-6152.33%
Net Profit Margin
-3779.08%0.00%-10561.06%-4762.13%-6127.56%
Continuous Operations Profit Margin
-3795.23%0.00%-11185.94%-4897.84%-6127.56%
Net Income Per EBT
84.08%99.85%94.41%97.23%99.60%
EBT Per EBIT
66.43%686.32%109.28%102.80%99.47%
Return on Assets (ROA)
-31.65%-303.00%-11.20%-75.98%-51.41%
Return on Equity (ROE)
-39.08%-791.49%-58.73%-103.44%-66.32%
Return on Capital Employed (ROCE)
-65.23%-49.16%-11.53%-98.22%-64.39%
Return on Invested Capital (ROIC)
-54.03%-48.34%-10.52%-94.32%-63.83%
Return on Tangible Assets
-35.87%-305.85%-11.23%-85.32%-59.24%
Earnings Yield
-12.06%-38.02%-9.05%-34.72%-16.13%
Efficiency Ratios
Receivables Turnover
0.12 0.00 2.02 1.24 0.08
Payables Turnover
0.06 0.77 7.08 0.00 0.00
Inventory Turnover
99.61K 0.00 <0.01 0.00 0.00
Fixed Asset Turnover
0.52 0.00 0.14 0.52 0.67
Asset Turnover
<0.01 0.00 <0.01 0.02 <0.01
Working Capital Turnover Ratio
0.01 0.00 <0.01 0.03 0.02
Cash Conversion Cycle
-3.12K -474.86 43.90K 295.39 4.32K
Days of Sales Outstanding
3.06K 0.00 180.87 295.39 4.32K
Days of Inventory Outstanding
<0.01 0.00 43.77K 0.00 0.00
Days of Payables Outstanding
6.18K 474.86 51.54 0.00 0.00
Operating Cycle
3.06K 0.00 43.96K 295.39 4.32K
Cash Flow Ratios
Operating Cash Flow Per Share
-0.09 -0.12 -0.22 -0.79 -0.69
Free Cash Flow Per Share
-0.10 -0.12 -0.22 -0.79 -0.70
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
1.02 1.00 1.02 1.00 1.01
Dividend Paid and CapEx Coverage Ratio
-58.66 -599.69 -66.64 -237.21 -114.28
Capital Expenditure Coverage Ratio
-58.66 -599.69 -66.64 -237.21 -114.28
Operating Cash Flow Coverage Ratio
-22.25 -0.72 -0.08 -26.09 -103.46
Operating Cash Flow to Sales Ratio
-24.63 0.00 -59.04 -40.13 -55.94
Free Cash Flow Yield
-7.99%-4.75%-5.14%-29.38%-14.85%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-8.29 -2.63 -11.05 -2.88 -6.20
Price-to-Sales (P/S) Ratio
313.35 0.00 1.17K 137.16 379.96
Price-to-Book (P/B) Ratio
3.24 20.82 6.49 2.98 4.11
Price-to-Free Cash Flow (P/FCF) Ratio
-12.51 -21.03 -19.47 -3.40 -6.73
Price-to-Operating Cash Flow Ratio
-12.72 -21.07 -19.76 -3.42 -6.79
Price-to-Earnings Growth (PEG) Ratio
0.04 -0.02 0.19 -0.13 -0.01
Price-to-Fair Value
3.24 20.82 6.49 2.98 4.11
Enterprise Value Multiple
-8.86 1.65K -18.85 -2.86 -7.02
Enterprise Value
148.78M 1.65B 991.83M 179.11M 260.81M
EV to EBITDA
-8.86 1.65K -18.85 -2.86 -7.02
EV to Sales
235.40 0.00 1.41K 99.01 303.27
EV to Free Cash Flow
-9.40 -21.49 -23.50 -2.46 -5.37
EV to Operating Cash Flow
-9.56 -21.52 -23.85 -2.47 -5.42
Tangible Book Value Per Share
0.31 0.12 0.65 0.77 0.95
Shareholders’ Equity Per Share
0.37 0.13 0.66 0.90 1.14
Tax and Other Ratios
Effective Tax Rate
0.16 <0.01 0.06 0.03 <0.01
Revenue Per Share
<0.01 0.00 <0.01 0.02 0.01
Net Income Per Share
-0.15 -0.99 -0.38 -0.93 -0.76
Tax Burden
0.84 1.00 0.94 0.97 1.00
Interest Burden
1.26 8.85 1.06 1.00 1.00
Research & Development to Revenue
51.75 0.00 73.83 47.18 61.95
SG&A to Revenue
11.45 0.00 37.91 13.05 22.36
Stock-Based Compensation to Revenue
0.86 0.00 14.03 5.23 1.50
Income Quality
0.65 0.12 0.53 0.82 0.91
Currency in GBP
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis